Chemosensitization of Human Renal Cell Cancer Using Antisense Oligonucleotides Targeting the Antiapoptotic Gene Clusterin
Open Access
- 1 January 2001
- Vol. 3 (4) , 360-367
- https://doi.org/10.1038/sj.neo.7900174
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000
- Interferon Gamma-1b Compared with Placebo in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 1998
- Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transferOncogene, 1998
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996
- Clusterin: Physiologic and pathophysiologic considerationsThe International Journal of Biochemistry & Cell Biology, 1995
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Expression of clusterin in human renal diseasesKidney International, 1994
- Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomasZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Therapeutic Applications of OligonucleotidesAnnual Review of Pharmacology and Toxicology, 1992